EV/EBITDA:
-7.39-0.11(-1.51%)Summary
- As of today, RARE EV/EBITDA is -7.39, with a fall of -0.11 (-1.51%) during the most recent trading session on October 13, 2025.
- Over the past year, RARE EV/EBITDA has increased by +3.33 (+31.06%).
- RARE EV/EBITDA is now -97.59% below its all-time high of -3.74.
Performance
RARE EV/EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
EV/EBITDA Formula
EV/EBITDA = Enterprise Value
TTM EBITDA
Enterprise Value
TTM EBITDA
TTM EBITDA
RARE EV/EBITDA Trends
| PeriodPeriod | EV/EBITDAEV/EBITDA | Enterprise ValueEnterprise Value | PricePrice |
|---|---|---|---|
| 1D1 Day | -1.5% | +1.6% | +1.8% |
| 1M1 Month | -5.0% | +5.0% | +5.6% |
| 3M3 Months | -7.4% | +7.5% | +8.5% |
| 6M6 Months | +1.7% | -3.4% | -6.2% |
| YTDYTD | +11.6% | -17.0% | -23.9% |
| 1Y1 Year | +31.1% | -35.4% | -41.9% |
| 5Y5 Years | +57.6% | -37.2% | -67.1% |
RARE EV/EBITDA Highs & Lows
| PeriodPeriod | HighHigh | Current vs Highvs High | LowLow | Current vs Lowvs Low | |
|---|---|---|---|---|---|
| 1M | 1-Month | -6.53 | -13.2% | -7.39 | at low |
| 3M | 3-Month | -6.22 | -18.8% | -7.40 | +0.1% |
| 6M | 6-Month | -6.22 | -18.8% | -9.32 | +20.7% |
| 1Y | 1-Year | -6.22 | -18.8% | -11.20 | +34.0% |
| 3Y | 3-Year | -4.03 | -83.4% | -11.20 | +34.0% |
| 5Y | 5-Year | -4.03 | -83.4% | -35.77 | +79.3% |
| All-Time | All-Time | -3.74 | -97.6% | -79.27 | +90.7% |
RARE EV/EBITDA History
| Date | Value |
|---|---|
| 2025 | -7.39(+11.6%) |
| 2024 | -8.36(-5.7%) |
| 2023 | -7.91(-46.2%) |
| 2022 | -5.41(+63.6%) |
| 2021 | -14.88(+46.2%) |
| 2020 | -27.64(-456.1%) |
| Date | Value |
|---|---|
| 2019 | -4.97(+0.2%) |
| 2018 | -4.98(+12.9%) |
| 2017 | -5.72(+44.5%) |
| 2016 | -10.30(+61.6%) |
| 2015 | -26.82(-23.9%) |
| 2014 | -21.64 |
FAQ
- What is Ultragenyx Pharmaceutical Inc. EV/EBITDA?
- What is the all-time high EV/EBITDA for Ultragenyx Pharmaceutical Inc.?
- What is RARE EV/EBITDA year-to-date change?
- What is Ultragenyx Pharmaceutical Inc. EV/EBITDA year-on-year change?
What is Ultragenyx Pharmaceutical Inc. EV/EBITDA?
The current EV/EBITDA of RARE is -7.39
What is the all-time high EV/EBITDA for Ultragenyx Pharmaceutical Inc.?
Ultragenyx Pharmaceutical Inc. all-time high EV/EBITDA is -3.74
What is RARE EV/EBITDA year-to-date change?
Ultragenyx Pharmaceutical Inc. EV/EBITDA has changed by +0.97 (+11.60%) since the beginning of the year
What is Ultragenyx Pharmaceutical Inc. EV/EBITDA year-on-year change?
Over the past year, RARE EV/EBITDA has changed by +3.33 (+31.06%)